HTRA3 and lung carcinoma: Moreover, forced HTRA3 expression significantly reduces lung cancer cell survival following treatment with etoposide and cisplatin, whereas an inactive mutant form of HtrA3 has no impact, suggesting that the protease activity of HtrA3 is essential in modulating drug-induced cytotoxicity in cancer cells [80].